Key terms
About ATAI
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Berlin, Germany.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest ATAI news
Mar 14
11:15am ET
Rising High: Exclusive talk with cannabis market research firm BDSA
Mar 11
7:53am ET
IntelGenx enters amended, restated loan agreement with atai Life Sciences
Mar 07
1:09pm ET
Rising High: Exclusive talk with multi-state operator C3 Industries
Mar 07
10:46am ET
Rising High: Exclusive talk with vape tech developer Ispire Technology
Mar 04
8:19am ET
Atai Life Sciences announces first patint dosed in Phase 1b trial of VLS-01
Feb 29
11:29am ET
Here’s What You Missed in Cannabis, Psychedelics This Week
Feb 29
11:29am ET
Here’s What You Missed in Cannabis, Psychedelics This Week
Feb 22
11:19am ET
Here’s What You Missed in Cannabis, Psychedelics This Week
Feb 22
11:19am ET
Here’s What You Missed in Cannabis, Psychedelics This Week
Feb 15
10:57am ET
Rising High: Exclusive talk with cannabis market research firm BDSA
Feb 15
10:57am ET
Rising High: Exclusive talk with cannabis market research firm BDSA
Feb 08
11:22am ET
Rising High: Exclusive talk with house of brands Carma HoldCo
Feb 08
11:22am ET
Rising High: Exclusive talk with house of brands Carma HoldCo
Feb 07
5:14am ET
ATAI Life Sciences Signals Executive Shakeup and Strategy Shift
Feb 07
5:14am ET
ATAI Life Sciences Announces New CFO Appointment and Transition
Feb 06
5:01pm ET
Atai Life Sciences names Anne Johnson CFO
Feb 01
11:35am ET
Rising High: Exclusive talk with drug manufacturer Optimi Health
Feb 01
11:35am ET
Rising High: Exclusive talk with drug manufacturer Optimi Health
Feb 01
11:21am ET
Rising High: Exclusive talk with drug manufacturer Optimi Health
Jan 25
11:09am ET
Here’s What You Missed in Cannabis, Psychedelics This Week
Jan 25
11:09am ET
Here’s What You Missed in Cannabis, Psychedelics This Week
Jan 25
4:55am ET
Atai Life Sciences participates in a conference call with Cantor Fitzgerald
Jan 24
3:08am ET
ATAI Life Sciences Finalizes Asset Acquisition Deal
Jan 24
3:08am ET
ATAI Life Sciences Secures Stake in Beckley Psytech
Jan 22
1:40pm ET
Analysts Offer Insights on Healthcare Companies: ATAI Life Sciences (ATAI), Halozyme (HALO) and Natera (NTRA)
Jan 22
11:32am ET
Atai Life Sciences participates in a conference call with Cantor Fitzgerald
Jan 18
10:57am ET
Here’s What You Missed in Cannabis, Psychedelics This Week
Jan 11
10:33am ET
Here’s What You Missed in Cannabis, Psychedelics This Week
Jan 04
11:02am ET
Here’s What You Missed in Cannabis, Psychedelics This Week
Jan 04
7:15am ET
Atai Life Sciences announces strategic investment in Beckley Psytech
Jan 02
10:45am ET
Buy Rating Affirmed for ATAI Life Sciences on Strong Clinical Data and Positive Valuation Outlook
No recent news articles are available for ATAI
No recent press releases are available for ATAI
ATAI Financials
Key terms
Ad Feedback
ATAI Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ATAI Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range